Risk of infection in roxadustat treatment for anemia in patients with chronic kidney disease: A systematic review with meta-analysis and trial sequential analysis

Background: Many studies demonstrated that roxadustat (FG-4592) could increase hemoglobin (Hb) levels effectively in anemia patients with chronic kidney disease (CKD). However, its safety remains controversial. This study aims to explore the risk of infection for CKD patients treated with roxadustat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Shan, Xie, Qiufen, Ma, Tiantian, Xiang, Qian, Zhou, Ying, Cui, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523222/
https://www.ncbi.nlm.nih.gov/pubmed/36188528
http://dx.doi.org/10.3389/fphar.2022.967532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523222/
https://www.ncbi.nlm.nih.gov/pubmed/36188528
http://dx.doi.org/10.3389/fphar.2022.967532

Ejemplares similares